S
Silvia Santopolo
Researcher at Sapienza University of Rome
Publications - 8
Citations - 104
Silvia Santopolo is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 68 citations.
Papers
More filters
Journal ArticleDOI
DOF AFFECTING GERMINATION 2 is a positive regulator of light-mediated seed germination and is repressed by DOF AFFECTING GERMINATION 1
Silvia Santopolo,Alessandra Boccaccini,Riccardo Lorrai,Veronica Ruta,Davide Capauto,Emanuele Minutello,Giovanna Serino,Paolo Costantino,Paola Vittorioso +8 more
TL;DR: The present data prove that DAG2 is a positive regulator of the light-mediated seed germination process, and particularly reveal that this protein plays its main role downstream of PIL5 and DAG1 in the phytochrome B (phyB)-mediated pathway.
Journal ArticleDOI
The DOF Protein DAG1 and the DELLA Protein GAI Cooperate in Negatively Regulating the AtGA3ox1 Gene
Alessandra Boccaccini,Silvia Santopolo,Davide Capauto,Riccardo Lorrai,Emanuele Minutello,Giovanna Serino,Paolo Costantino,Paola Vittorioso +7 more
TL;DR: This work has demonstrated that DAG1 specifi cally represses AtGA3ox1 expression, and confirmed that GAI plays a role in the regulation of GA metabolic genes, and in particular of AtGA2ox1, and performed a quantitative RT–PCR analysis on gai-t6 mutant seeds.
Journal ArticleDOI
Independent and interactive effects of DOF affecting germination 1 (DAG1) and the Della proteins GA insensitive (GAI) and Repressor of ga1-3 (RGA) in embryo development and seed germination.
Alessandra Boccaccini,Silvia Santopolo,Davide Capauto,Riccardo Lorrai,Emanuele Minutello,Katia Belcram,Jean-Cristophe Palauqui,Paolo Costantino,Paola Vittorioso +8 more
TL;DR: It is shown that RGA and GAI play distinct roles in seed germination, and that GAI interacts with DAG1 in embryo development.
Journal ArticleDOI
Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence
Anna Riccio,Silvia Santopolo,Antonio Rossi,Sara Piacentini,Jean-Francois Rossignol,M. Gabriella Santoro +5 more
TL;DR: In this article , the authors demonstrate that nitazoxanide, an antiprotozoal agent with recognized broad-spectrum antiviral activity, interferes with SARS-CoV-2 spike maturation, hampering its terminal glycosylation at an endoglycosidase H-sensitive stage.
Posted ContentDOI
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein
Sara Piacentini,Anna Riccio,Silvia Santopolo,Silvia Pauciullo,Simone La Frazia,Antonio Rossi,Jean-Francois Rossignol,M. Gabriella Santoro +7 more
TL;DR: The results indicate that nitazoxanide, due to its broad-spectrum anti-coronavirus activity, may represent a readily available useful tool in the treatment of seasonal coronavirus infections.